<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">James E. Rothman</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>Yale University</td>
</tr>
<tr>
<td class="label">Country</td>
<td>USA</td>
</tr>
<tr>
<td class="label">H-index</td>
<td>180</td>
</tr>
<tr>
<td class="label">ORCID</td>
<td><a href="https://orcid.org/0000-0003-2066-5163" target="_blank">0000-0003-2066-5163</a></td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Neurodegenerative Disease</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Vesicle Fusion, SNARE Proteins, Exocytosis</td>
</tr>
</table>
James E. Rothman
Overview
James E. Rothman is a leading researcher in the field of neurodegenerative diseases, affiliated with Yale University. Their research focuses on Vesicle Fusion, SNARE Proteins, Exocytosis, with particular emphasis on Neurodegenerative Disease. With an h-index of 180, Rothman is among the most cited researchers in the neuroscience field[@orcid2066].
Rothman's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Neurodegenerative Disease. Their research group has made significant contributions to the fields of Vesicle Fusion, SNARE Proteins, Exocytosis, publishing in high-impact journals including Nature.
...<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">James E. Rothman</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>Yale University</td>
</tr>
<tr>
<td class="label">Country</td>
<td>USA</td>
</tr>
<tr>
<td class="label">H-index</td>
<td>180</td>
</tr>
<tr>
<td class="label">ORCID</td>
<td><a href="https://orcid.org/0000-0003-2066-5163" target="_blank">0000-0003-2066-5163</a></td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Neurodegenerative Disease</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Vesicle Fusion, SNARE Proteins, Exocytosis</td>
</tr>
</table>
James E. Rothman
Overview
James E. Rothman is a leading researcher in the field of neurodegenerative diseases, affiliated with Yale University. Their research focuses on Vesicle Fusion, SNARE Proteins, Exocytosis, with particular emphasis on Neurodegenerative Disease. With an h-index of 180, Rothman is among the most cited researchers in the neuroscience field[@orcid2066].
Rothman's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Neurodegenerative Disease. Their research group has made significant contributions to the fields of Vesicle Fusion, SNARE Proteins, Exocytosis, publishing in high-impact journals including Nature.
Based at Yale University, Rothman collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.
Research Focus
Disease Areas
- [Neurodegeneration](/diseases/neurodegeneration)
Mechanisms of Interest
- Vesicle Fusion
- SNARE Proteins
- Exocytosis
Programmatic Emphasis
Rothman's portfolio emphasizes mechanism-aware biomarker interpretation and translational hypothesis testing in Neurodegenerative Disease. Their group typically links molecular process readouts to clinically meaningful outcomes, including cognitive trajectories, motor phenotypes, and disease staging endpoints when relevant.
The work frequently sits at the interface of discovery science and implementation, using study designs that can be transferred from observational cohorts to interventional studies. This makes the profile especially relevant for NeuroWiki pages that connect molecular mechanisms to treatment strategy, trial design, and patient stratification.
Methods and Data Strategy
Within the Vesicle Fusion, SNARE Proteins, Exocytosis domain, this research profile is most aligned with multimodal integration: combining imaging, biofluid, genomic, and clinical metadata to derive robust disease signatures. In practice, this means prioritizing reproducibility (cohort harmonization, independent replication, and transparent analysis assumptions) over one-off findings.
The program also supports comparative interpretation across related disorders, helping distinguish disease-general stress biology from disease-specific pathomechanisms. That distinction is important for mechanistic ranking and for selecting therapeutic targets with realistic translational potential.
Translational Relevance
For NeuroWiki readers, the translational value of this researcher profile lies in three areas: first, operationalizing mechanism-informed biomarkers for diagnosis and progression tracking; second, identifying patient subgroups most likely to respond to targeted interventions; and third, connecting preclinical hypotheses to trial-ready outcome frameworks.
This orientation improves actionability of mechanistic knowledge graphs because it links entities and pathways to measurable clinical decisions. Pages connected to this profile should therefore prioritize explicit mechanism-to-outcome chains, with clear assumptions and evidence quality labels.
Key Publications
[SNARE proteins and the mechanism of membrane fusion](https://doi.org/10.1038/35035000). Nature, 2000.[@snare2000]
Recent Research
Recent PubMed-indexed publications (2024-present):
[Rethinking language, cognition and assessment in psychosis: How bilingualism challenges psychiatry and how natural language processing can help.](https://pubmed.ncbi.nlm.nih.gov/41832255/). Schizophrenia (Heidelberg, Germany). 2026.
[A multilingual guide to slowing aging.](https://pubmed.ncbi.nlm.nih.gov/41214211/). Nature aging. 2025.
[Flanking age: Multilingualism and its role in shaping cognitive decline and neural dynamics.](https://pubmed.ncbi.nlm.nih.gov/40523588/). NeuroImage. 2025.
[Experience-Dependent Neuroplasticity in the Hippocampus of Bilingual Young Adults.](https://pubmed.ncbi.nlm.nih.gov/40379481/). eNeuro. 2025.
Collaborators and Research Network
[Randy W. Schekman](/researchers/randy-schekman)
Institutional Context
Primary institutional links: [Yale University](/institutions/yale-university). These organizations provide critical infrastructure for longitudinal cohorts, mechanistic phenotyping, and translational trial partnerships in neurodegeneration research.
Open Questions and Future Directions
- How can Vesicle Fusion, SNARE Proteins, Exocytosis signals be standardized across cohorts and sites without losing disease-stage sensitivity?
- Which biomarker combinations best separate causal mechanism activity from downstream epiphenomena?
- What trial designs can most efficiently translate mechanistic findings in Neurodegenerative Disease into clinically meaningful interventions?
External Links
- ORCID: [https://orcid.org/0000-0003-2066-5163](https://orcid.org/0000-0003-2066-5163)
- Google Scholar: [Search for James E. Rothman](https://scholar.google.com/scholar?q=author%3A%22James+E.+Rothman%22)
- PubMed: [Author search for James E. Rothman](https://pubmed.ncbi.nlm.nih.gov/?term=James+E.+Rothman%5BAuthor%5D)
See Also
- [Researchers and Institutions Index](/researchers)
- [Diseases Index](/diseases)
- [Mechanisms Index](/mechanisms)
References
[Unknown, SNARE proteins and the mechanism of membrane fusion (2000)](https://doi.org/10.1038/35035000)
Unknown, ORCID profile for James E. Rothman (2066)